Antivirals Reduce the Formation of Key Alzheimer's Disease Molecules in Cell Cultures Acutely Infected with Herpes Simplex Virus Type 1

Valacyclovir for Herpes Simplex Encephalitis

(2011) Thomas Pouplin et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Activation of PKR Causes Amyloid ß-Peptide Accumulation via De-Repression of BACE1 Expression

(2011) Gerard ILL-Raga et al.   PLoS One

Therapeutic implications of new insights into the critical role of VP16 in initiating the earliest stages of HSV reactivation from latency

(2010) Richard L Thompson et al.   Future Medicinal Chemistry

Acyclovir or Aβ42 peptides attenuate HSV-1-induced miRNA-146a levels in human primary brain cells

(2010) Walter J. Lukiw et al.   NEUROREPORT

APP Processing Induced by Herpes Simplex Virus Type 1 (HSV-1) Yields Several APP Fragments in Human and Rat Neuronal Cells

(2010) Giovanna De Chiara et al.   PLoS One

APOE genotype is associated with oral herpetic lesions but not genital or oral herpes simplex virus shedding

(2010) D. M. Koelle et al.   SEXUALLY TRANSMITTED INFECTIONS

Antiviral agents in Alzheimer’s disease: hope for the future?

(2010) Matthew A. Wozniak et al.   Therapeutic Advances in Neurological Disorders

HIV Regulation of Amyloid Beta Production

(2009) Lynn Pulliam   Journal of Neuroimmune Pharmacology

Herpes simplex virus type 1 DNA is located within Alzheimer's disease amyloid plaques

(2008) MA Wozniak et al.   JOURNAL OF PATHOLOGY